Title:
CELL DEATH INDUCER, CELL PROLIFERATION INHIBITOR, AND PHARMACEUTICAL COMPOSITION FOR TREATING DISEASE ASSOCIATED WITH ABNORMAL CELL PROLIFERATION
Document Type and Number:
WIPO Patent Application WO/2017/222035
Kind Code:
A1
Abstract:
It becomes possible to induce cell death of cancer cells and inhibit cell proliferation of cancer cells. A medicinal agent capable of inhibiting both of GST-π and MRPL17 is contained as an active ingredient, or a medicinal agent capable of inhibiting GST-π and a medicinal agent capable of inhibiting MRPL17 are contained as active ingredients.
Inventors:
TANAKA HIROYUKI (JP)
MINOMI KENJIROU (JP)
MINOMI KENJIROU (JP)
Application Number:
PCT/JP2017/023121
Publication Date:
December 28, 2017
Filing Date:
June 23, 2017
Export Citation:
Assignee:
NITTO DENKO CORP (JP)
International Classes:
A61K45/00; A61K31/7088; A61K31/7105; A61K31/713; A61K45/06; A61K48/00; A61P35/00; A61P43/00
Domestic Patent References:
| WO2015194522A1 | 2015-12-23 |
Foreign References:
| JP2002510490A | 2002-04-09 |
Other References:
See also references of EP 3476401A4
Attorney, Agent or Firm:
HIRAKI & ASSOCIATES (JP)
Download PDF:
Previous Patent: MODIFIED FIBROIN
Next Patent: COMPOUND, ORGANIC EL ELEMENT, DISPLAY DEVICE, AND ILLUMINATION DEVICE
Next Patent: COMPOUND, ORGANIC EL ELEMENT, DISPLAY DEVICE, AND ILLUMINATION DEVICE